|
|
||||||||||
A.W. Jowdy Professor of Pharmacy Care, College of Pharmacy, The University of Georgia, Athens, GA
Adjunct Professor of Law in Health and Medicine, School of Law, Oklahoma City University, Oklahoma City, OK; Chief of Endrocrinology, Chicasaw Nation, Ada, OK
Professor and Dean, College of Pharmacy, Washington State University, Pullman, WA
Assistant Dean, School of Pharmacy, Palm Beach Atlantic University, West Palm Beach, FL
Reprints: Dr. Fincham, College of Pharmacy, The University of Georgia, Rm. 262, DW Brooks Dr., Athens, GA 30602-2351, fax 706/583-0034, jfincham{at}uga.edu
The controversy surrounding the potential switch of the Plan B emergency contraceptive therapy from prescription to over-the-counter status has been unprecedented. Regulatory, professional, and societal aspects of this issue have been discussed recently and will no doubt continue to be debated. In this editorial, members of the Medicine, Law, and Ethics panel of The Annals of Pharmacotherapy's Editorial Board offer a sampling of viewpoints touching on varying aspects of the controversy. Readers may wish to consider the ramifications of their professional decisions in this and similar situations in advance of having to make such decisions.
Published Online, January 4, 2005. www.theannals.com, DOI 10.1345/aph.1E649
This article has been cited by other articles:
![]() |
W. E Fassett Ethics, Law, and the Emergence of Pharmacists' Responsibility for Patient Care Ann. Pharmacother., July 1, 2007; 41(7): 1264 - 1267. [Full Text] [PDF] |
||||